When is the next results date for Mangalam Drugs and Organics Ltd?
2026-08-06 23:18:53The next results date for Mangalam Drugs and Organics Ltd is scheduled for 12 August 2026....
Read full news article
Mangalam Drugs and Organics Ltd is Rated Strong Sell
2026-07-29 10:10:57Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 29 July 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Mangalam Drugs and Organics Ltd is Rated Strong Sell
2026-07-15 10:11:02Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 15 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and overall outlook.
Read full news article
Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 2.84% Gain — Buyers Queue, Sellers Absent
2026-07-15 10:00:07At Rs 28.79, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 2.84% on 15 Jul 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 3.38% Gain — Buyers Queue, Sellers Absent
2026-07-09 15:00:07At Rs 28.27, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 3.38% on 9 Jul 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Mangalam Drugs and Organics Ltd is Rated Strong Sell
2026-07-01 10:10:43Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 01 July 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Mangalam Drugs and Organics Ltd is Rated Strong Sell
2026-06-18 10:10:34Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 1.88% Gain — Buyers Queue, Sellers Absent
2026-06-15 11:00:06At Rs 29.58, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 5% on 15 Jun 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Mangalam Drugs and Organics Ltd is Rated Strong Sell
2026-06-05 10:10:20Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 08 June 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall market standing.
Read full news articleIntimation Of Resignation Tendered By Ragini Chokshi & Co. Secretarial Auditor Of The Company W.E.F. 4Th August 2026.
06-Aug-2026 | Source : BSEIntimation pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations 2015 regarding resiagntion tendered by Ragini Chokshi & Co. Secretarial Auditor of the Company w..e.f. 4th August 2026.
Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On August 12Th 2026 Inter Alia To Approve Un-Audited Financial Results(Standalone & Consolidated) Alongwith Limited Review Report For The Quarter Ended 30Th June 2026.
05-Aug-2026 | Source : BSEMangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Prior Intimation as per Regulation 29 of SEBI(LODR) Regulations 2015 of Board meeting to be held on August 12th 2026 inter alia to approve un-audited Financial Results(Standalone & Consolidated) alongwith limited review report for the quarter ended 30th June 2026.
Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure
16-Jul-2026 | Source : BSEIntimation of subsequent default under Para A sub-paragraph 6 of Schedule III
Corporate Actions
12 Aug 2026
Mangalam Drugs and Organics Ltd has declared 5% dividend, ex-date: 21 Dec 17
No Splits history available
No Bonus history available
No Rights history available






